Invention Application
- Patent Title: USE OF ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES FOR THE TREATMENT OF GLAUCOMA
-
Application No.: US16626630Application Date: 2018-06-27
-
Publication No.: US20200157202A1Publication Date: 2020-05-21
- Inventor: Bongcheol KIM , Dong Sik KIM , Soon-gu KWON
- Applicant: Neuracle Science Co., Ltd.
- Applicant Address: KR Seoul
- Assignee: Neuracle Science Co., Ltd.
- Current Assignee: Neuracle Science Co., Ltd.
- Current Assignee Address: KR Seoul
- International Application: PCT/IB2018/054782 WO 20180627
- Main IPC: C07K16/24
- IPC: C07K16/24
Abstract:
The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to treat a glaucoma in a subject in need thereof.
Public/Granted literature
- US11746149B2 Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment of glaucoma Public/Granted day:2023-09-05
Information query
